New perspectives in stem cell research: Beyond embryonic stem cells

Cell Proliferation

Volumn 44, Issue SUPPL. 1, 2011, Pages 9-14

  Leeb, C ^a   Jurga, M ^b   Mcguckin, C ^b   Forraz, N ^b   Thallinger, C ^c   Moriggl, R ^d   Kenner, L ^c,d  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Cell Therapy Research Institute   (France)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT STEM CELL; ARTICLE; CELL DIFFERENTIATION; CLINICAL RESEARCH; DIABETES MELLITUS; DISEASE MODEL; EMBRYONIC STEM CELL; HEART DISEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; STEM CELL; STEM CELL TRANSPLANTATION; TERATOMA;

ANIMALS; EMBRYONIC STEM CELLS; HUMANS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

ANIMALIA;

EID: 79953889302     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00725.x     Document Type: Article

References (44)

1. Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
2. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634-7638.
3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
4. Gurdon JB, Elsdale TR, Fischberg M (1958) Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 182, 64-65.
5. French AJ, Adams CA, Anderson LS, Kitchen JR, Hughes MR, Wood SH (2008) Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells 26, 485-493.
6. Gurdon JB, Melton DA (2008) Nuclear reprogramming in cells. Science 322, 1811-1815.
7. Cowan CA, Atienza J, Melton DA, Eggan K (2005) Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369-1373.
8. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
9. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
10. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
11. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W et al. (2008) Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
12. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A et al. (2008) Disease-specific induced pluripotent stem cells. Cell 134, 877-886.
13. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG et al. (2009) Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964-977.
14. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K (2008) Induced pluripotent stem cells generated without viral integration. Science 322, 945-949.
15. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953.
16. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, Han BS et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472-476.
17. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hamalainen R et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766-770.
18. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381-384.
19. Maherali N, Hochedlinger K (2008) Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3, 595-605.
20. McCulloch E.A., Till J.E. (1960) The radiation sensitivity of normal mouse bone marrow cells, determined by quantitative marrow transplantation into irradiated mice. Radiation Research 13, 115-125.
21. Flomenberg N, Devine SM, Dipersio JF, Liesveld JL, McCarty JM, Rowley SD et al. (2005) The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 106, 1867-1874.
22. Leeb C, Jurga M, McGuckin C, Moriggl R, Kenner L (2010) Promising new sources for pluripotent stem cells. Stem Cell Rev. 6, 15-26.
23. Broxmeyer HE (2010) Umbilical cord transplantation: epilogue. Semin. Hematol. 47, 97-103.
24. Perry AR, Linch DC (1996) The history of bone-marrow transplantation. Blood Rev. 10, 215-219.
25. Curtis MA, Penney EB, Pearson AG, van Roon-Mom WM, Butterworth NJ, Dragunow M et al. (2003) Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc. Natl. Acad. Sci. USA 100, 9023-9027.
26. Shan X, Chi L, Bishop M, Luo C, Lien L, Zhang Z et al. (2006) Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease-like mice. Stem Cells 24, 1280-1287.
27. Lindvall O, Kokaia Z, Martinez-Serrano A (2004) Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10(Suppl.), S42-S50.
28. Boucherie C, Hermans E (2009) Adult stem cell therapies for neurological disorders: benefits beyond neuronal replacement? J. Neurosci. Res. 87, 1509-1521.
29. Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y et al. (2008) Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy 10, 340-352.
30. Murrell W, Wetzig A, Donnellan M, Feron F, Burne T, Meedeniya A et al. (2008) Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease. Stem Cells 26, 2183-2192.
31. Cho MS, Lee YE, Kim JY, Chung S, Cho YH, Kim DS et al. (2008) Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 105, 3392-3397.
32. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F et al. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105, 5856-5861.
33. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA et al. (2008) Clinical transplantation of a tissue-engineered airway. Lancet 372, 2023-2030.
34. Segers VF, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451, 937-942.
35. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S et al. (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443-452.
36. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA (2008) In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455, 627-632.
37. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD et al. (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. USA 103, 17438-17443.
38. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F et al. (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297, 1568-1576.
39. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, Barros GM et al. (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301, 1573-1579.
40. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K et al. (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 25, 4694-4705.
41. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923.
42. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A (2009) Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120, 408-416.
43. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ et al. (2009) Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 460, 53-59.
44. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW (2009) Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc. Natl. Acad. Sci. USA 106, 9826-9830.